Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery

Abroad (travel likely)RecruitingPHASE2

Conditions

Neoadjuvant Treatment · Thyroid Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, United States
Contact: Study coordinator (Jessica Geiger, MD) · geigerj@ccf.org
Contact: Principal Investigator (Jessica Geiger, MD)
MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Mark Zafero, MD) · mzafereo@mdanderson.org · 713-563-9683
Contact: Principal Investigator (Mark Zafereo, MD)
University of Virginia, Charlottesville, Virginia, United States
Contact: Study coordinator (Varinder Kaur, MD) · vk4q@uvahealth.org · 434-297-4054
Contact: Principal Investigator (Varinder Kaur, MD)

Study leads

Mark Zafereo, MD
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov